In 1998 as Merck was running clinical trials for Vioxx, company reports to the FDA stated that there were no cardiovascular signals apparent. This meant that there were no telltale signs that the drug could cause heart problems for users. Later, however, it was revealed that an internal study conducted by Merck around the same time – Study 090 – revealed serious cardiovascular problems as compared to patients not taking Vioxx. The study was never published by Merck as the company insisted that it was not large enough to provide definitive data.
The following year the FDA gave Vioxx its approval and the drug became the second nonsteroidal anti-inflammatory medication [or COX-2 inhibitor] to hit the market. Celebrex, another problem drug, was the first.
Merck widely and thoroughly launched a marketing campaign upon the introduction of Vioxx to the marketplace. Indeed, by 2003 the drug had entered 80 nations with sales exceeding $2.5 billion. Still, there were problems looming as ongoing tests conducted by Merck hinted of potential deadly side effects.
As early as 2001, the FDA recommended label warnings be put on prescriptions warning users of potential side effects. In addition, Merck was warned by the FDA to quit misleading physicians about potential side effects.
As potential problems began to surface, they served as red flags to industry watchdogs, to the FDA, as well as to personal injury attorneys who began to gather evidence to show that Merck was negligent. Indeed, web sites and advertising campaigns – meant to inform and attract patients harmed by the drug – were launched and fairly soon the internet, radio, television, and print media were flooded with advertisements asking those suspecting harm from Vioxx to come forward.
With the September 2004 announcement that Merck was withdrawing Vioxx, personal injury litigation was well on its way to being established. By early 2005, the first cases were filed and the Ernst case became the first Vioxx lawsuit to be settled.
Wrongful death lawsuits against Vioxx’s maker, Merck, are expected to increase as the result of the Ernst decision. Personal injury attorneys insist that thousands of former Vioxx users and/or their families are due compensation for Merck’s neglect. It remains to be seen if juries will render judgments as large as the Ernst judgment and whether courts will uphold these amounts. Nevertheless, it is certain that Merck is in for a long battle that will reach well beyond its US base.
More Post
New Medicines Available To Treat Rare Diseases
Music now we learn also on-line
Give A Heart Necklace This Holiday
Cure your Baldness & Alopecia the Natural Way (Chinese Herbs)
Teach Courses Online
Facts About Spirulina- Worlds Most Powerful Food
School Fundraiser Niche - Valentines Day
Hair Loss: Cosmetic Solutions For Good Cover Up
Dating Blindly
Sun Tanning Protects The Skin
Thay Call It "Dog Breath" For A Reason
Using Magnets To Fight The Pain
A Note From Saint Valentine - A First Person Tale Of This Wonderful Day
Spitting Up – And Other Joys Of Motherhood
Las Vegas: How to Ensure Your Vacation is Full of Adventure and Kicks
Is Self-Esteem Contrary to Christianity
What Educational Toys Do Kids Actually Enjoy Playing With?
MLM Success | Relationships in Two Minutes Flat
Are vent free gas fireplaces safe?
Domestic Violence Dr Jekyll or Mr Hyde